Improving Financial Health slide image

Improving Financial Health

Recent performance Highlights FY21 Growths Constant FX rates Actual FX rates Total revenue 7% 4% Results USD US$5,357m 28% Q1 FY22 Growths Constant FX rates Actual FX rates 31% Revenue Organic revenue 4% 22% Benchmark EBIT growth 3% 0% $1,385m EBIT Benchmark EBIT margin 25.9% EPS Benchmark EPS growth 4% 0% 103.1c Operating cash flow Benchmark operating cash flow conversion 106% $1,476m Benchmark operating cash flow growth 22% Dividend Total dividend per share growth 0% 47.0c Funding and liquidity Net debt to benchmark EBITDA 2.2x Certain financial data have been rounded within this presentation. As a result of this rounding, the totals of data presented may vary slightly from the arithmetic totals of such data. Revenue, Benchmark EBIT growths and Benchmark EBIT margin are on an ongoing activities basis. 1 As at 31 March 2021. 24 Experian Public experian
View entire presentation